• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

50例慢性丙型肝炎患者的随访研究:脂联素作为重度抑郁症的恢复力生物标志物

A Follow-Up Study of 50 Chronic Hepatitis C Patients: Adiponectin as a Resilience Biomarker for Major Depression.

作者信息

Fábregas Bruno C, Vieira Érica L M, Moura Alexandre S, Carmo Ricardo A, Ávila Renata E, Abreu Mery N S, Prossin Allan R, Teixeira Antônio L

机构信息

Tropical Medicine Program, School of Medicine, Municipal Health Division/Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

出版信息

Neuroimmunomodulation. 2016;23(2):88-97. doi: 10.1159/000444531. Epub 2016 Apr 2.

DOI:10.1159/000444531
PMID:27035148
Abstract

OBJECTIVE

Major depression (MD) is a condition associated with both hepatitis C virus (HCV) infection and pegylated interferon (IFN)-α treatment. IFN induces a depressive syndrome that is associated with an inflammatory profile. We aimed to investigate whether there is any specific alteration in plasma biomarkers associated with MD.

METHODS

HCV-monoinfected patients, with and without IFN treatment, were followed up for 18 months and went through structured psychiatric evaluation. We assessed plasma levels of brain-derived neurotrophic factor, tumor necrosis factor (TNF) and its soluble type 1 and type 2 receptors (sTNFR1 and sTNFR2, respectively), and adipokines (adiponectin, leptin and resistin) using ELISA.

RESULTS

Among the 50 patients included in the study, 14 were treated with IFN during the follow-up. Being older, not married, presenting higher body mass index, higher liver inflammatory activity, lower baseline adiponectin levels and use of IFN were associated with MD development. Higher levels of sTNFR1 during IFN treatment were associated with sustained virological response. The lack of a control group without HCV infection did not allow any assumption of a biomarker change exclusively due to the infection itself.

CONCLUSION

Adiponectin may be a resilience biomarker for MD in HCV-infected patients.

摘要

目的

重度抑郁症(MD)与丙型肝炎病毒(HCV)感染及聚乙二醇化干扰素(IFN)-α治疗均有关联。IFN可诱发一种与炎症特征相关的抑郁综合征。我们旨在研究与MD相关的血浆生物标志物是否存在任何特异性改变。

方法

对接受和未接受IFN治疗的HCV单感染患者进行为期18个月的随访,并进行结构化精神评估。我们使用酶联免疫吸附测定法评估血浆中脑源性神经营养因子、肿瘤坏死因子(TNF)及其可溶性1型和2型受体(分别为sTNFR1和sTNFR2)以及脂肪因子(脂联素、瘦素和抵抗素)的水平。

结果

在纳入研究的50例患者中,14例在随访期间接受了IFN治疗。年龄较大、未婚、体重指数较高、肝脏炎症活动度较高、基线脂联素水平较低以及使用IFN与MD的发生有关。IFN治疗期间sTNFR1水平较高与持续病毒学应答有关。缺乏未感染HCV的对照组,因此无法假定生物标志物的变化完全是由感染本身所致。

结论

脂联素可能是HCV感染患者MD的一种恢复力生物标志物。

相似文献

1
A Follow-Up Study of 50 Chronic Hepatitis C Patients: Adiponectin as a Resilience Biomarker for Major Depression.50例慢性丙型肝炎患者的随访研究:脂联素作为重度抑郁症的恢复力生物标志物
Neuroimmunomodulation. 2016;23(2):88-97. doi: 10.1159/000444531. Epub 2016 Apr 2.
2
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.脂联素:慢性丙型肝炎中肝脂肪变性及对干扰素-α治疗反应的新型独立预测因子。
Am J Gastroenterol. 2008 Mar;103(3):605-14. doi: 10.1111/j.1572-0241.2007.01729.x. Epub 2008 Jan 8.
3
Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.脂肪细胞因子与胰岛素抵抗:埃及慢性丙型肝炎病毒基因 4 型患者对治疗反应的预测因子。
Eur J Gastroenterol Hepatol. 2013 Aug;25(8):920-5. doi: 10.1097/MEG.0b013e32835f2726.
4
Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.丙型肝炎 4 型病毒治疗期间和治疗后的脂肪细胞因子和胰岛素敏感性变化。
J Gastrointestin Liver Dis. 2012 Mar;21(1):59-65.
5
Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy.慢性乙型和丙型肝炎感染患者的脂联素水平及对α干扰素治疗的反应。
Liver Int. 2005 Aug;25(4):752-9. doi: 10.1111/j.1478-3231.2005.1007.x.
6
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.慢性丙型肝炎患者(而非肝细胞癌患者)甲胎蛋白升高的预测因素及其在聚乙二醇化干扰素α-2a-利巴韦林联合治疗后的恢复正常情况。
J Gastroenterol Hepatol. 2007 May;22(5):669-75. doi: 10.1111/j.1440-1746.2007.04898.x.
7
Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.基于干扰素的疗法实现的持续丙型肝炎病毒清除可降低乙肝和丙肝双重感染患者的肝细胞癌发生率。
Antivir Ther. 2011;16(7):959-68. doi: 10.3851/IMP1842.
8
Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎合并隐匿性乙型肝炎病毒双重感染患者的疗效。
J Gastroenterol Hepatol. 2010 Feb;25(2):259-63. doi: 10.1111/j.1440-1746.2009.06006.x. Epub 2009 Oct 9.
9
Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b.血清载脂蛋白 B-100 浓度可预测慢性丙型肝炎病毒 1b 基因型感染患者对聚乙二醇干扰素联合利巴韦林治疗的病毒学应答。
J Med Virol. 2013 Jul;85(7):1180-90. doi: 10.1002/jmv.23597.
10
Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.慢性丙型肝炎病毒感染患者血清脂肪因子水平:与脂肪变性和肝纤维化的关系
Arch Med Res. 2009 May;40(4):294-8. doi: 10.1016/j.arcmed.2009.04.008.

引用本文的文献

1
Increasing Adiponergic System Activity as a Potential Treatment for Depressive Disorders.增加脂联素系统活性作为治疗抑郁障碍的一种潜在方法。
Mol Neurobiol. 2019 Dec;56(12):7966-7976. doi: 10.1007/s12035-019-01644-3. Epub 2019 May 28.
2
Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?抑郁症与慢性肝病:是否存在共同的潜在机制?
Front Mol Neurosci. 2017 May 8;10:134. doi: 10.3389/fnmol.2017.00134. eCollection 2017.